Acupuncture
Conditions
Brief summary
Objective: obesity is an important risk factor of chronic diseases, which not only threatens people's health, but also an important topic of public health. The purpose of this study is to define obesity according to the norms of the World Health Organization, and to explore whether combined weight loss methods have an impact on weight loss. Methods: In this study, Combined treatment of abdominal acupoint catgut embedding was combined with auricular pellet acupressure, The wire used for catgut embedding in the experiment was polydioxanone (PDO) 。 This experiment was divided into two groups: the experimental group A and the control group B 。 The reference measurement basis is the data obtained by Inbody instrument, including height and weight, body mass index (BMI), basic metallic rate (BMR), Body Fat Percentage BFP) , waist hip ratio and the data of total cholesterol (TC) and triglycerides (TG) obtained from biochemical blood examination, through the comparison before and after the test, we can judge whether the method of this test can achieve a certain degree of curative effect on weight loss.
Detailed description
Objective: obesity is an important risk factor of chronic diseases, which not only threatens people's health, but also an important topic of public health. The purpose of this study is to define obesity according to the norms of the World Health Organization, and to explore whether combined weight loss methods have an impact on weight loss. Methods: In this study, This study is a random Single Blind Random Blind Trial conducted at Acupuncture and Moxibustion department of China Medical University hospital, Taichung city, Taiwan. The study involved 2 groups divided in 1:1 ratio to an intervention group and a control group. The study Combined treatment of abdominal acupoint catgut embedding was combined with auricular pellet acupressure, The wire used for catgut embedding in the experiment was polydioxanone (PDO) 。 This experiment was divided into two groups: the experimental group and the control group。The reference measurement basis is the data obtained by Inbody instrument, including height and weight, body mass index (BMI), basic metallic rate (BMR), Body Fat Percentage BFP), waist hip ratio and the data of total cholesterol (TC) and triglycerides (TG) obtained from biochemical blood examination, through the comparison before and after the test, we can judge whether the method of this test can achieve a certain degree of curative effect on weight loss.
Interventions
OTHERCatgut Embedding at acupoints
Supplemented by auricular point therapy, can increase the effect of catgut embedding therapy.
Sponsors
China Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
Masking patients and statistician
Intervention model description
two groups, randomized, pre-post intervention study
Eligibility
Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
A. Age 25 to 45 years old B. In line with the World Health Organization's BMI standard diagnosis ≥ 25 C. Waist circumference of men ≥90 cm or waist circumference of women ≥80 cm D. Body fat rate of men\>25%, body fat rate of women\>30% E. The above B, C, D can be included if they meet one of them F. Complete written informed consent
Exclusion criteria
* A. Pregnant, breastfeeding, menopausal women B. There are malignant tumors of the heart, liver and kidneys C. Diagnosed with mental illness D. Participated in another study within three months E. There are people who are taking diet pills
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| body weight | 12 weeks | body weight in kilograms measured at inclusion and at 12 weeks measured by InBody body analysis instrument |
| BMI | 12 weeks | Body mass index (BMI) measured at inclusion and at 12 weeks measured by InBody body analysis instrument |
| basal metabolic rate | 12 weeks | basal metabolic rate measured at inclusion and at 12 weeks measured by InBody body analysis instrument |
| Body fat percentage | 12 weeks | Body fat percentage measured at inclusion and at 12 weeks measured by InBody body analysis instrument |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Triglycerides | 12 weeks | Triglycerides levels in blood measured by blood tests on inclusion and at 12 weeks |
| waist hip ratio | 12 weeks | waist hip ratio measured at inclusion and at 12 weeks measured by InBody body |
| Total cholesterol | 12 weeks | Total cholesterol levels in blood measured by blood tests on inclusion and at 12 weeks |
| WHOQOL | 12 weeks | WHOQOL numerical assessment of quality of life, fill in the questionnaire before the first treatment. |
| Skeletal muscle weight | 12 weeks | Skeletal muscle weight measured at inclusion and at 12 weeks measured by InBody body analysis instrument |
Countries
Taiwan
Outcome results
None listed